Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cost-Benefit Analysis | 62 | 2016 | 5391 | 1.660 |
Why?
|
Health Expenditures | 17 | 2018 | 2348 | 1.620 |
Why?
|
Health Care Costs | 18 | 2014 | 3209 | 1.110 |
Why?
|
Comparative Effectiveness Research | 4 | 2011 | 681 | 1.050 |
Why?
|
Technology Assessment, Biomedical | 7 | 2007 | 306 | 1.010 |
Why?
|
Medicare | 14 | 2018 | 6566 | 1.010 |
Why?
|
Quality-Adjusted Life Years | 29 | 2016 | 1683 | 0.760 |
Why?
|
Biomedical Technology | 5 | 2006 | 220 | 0.710 |
Why?
|
Health Services Research | 8 | 2009 | 1836 | 0.710 |
Why?
|
Natural Language Processing | 4 | 2009 | 1041 | 0.700 |
Why?
|
Diffusion of Innovation | 4 | 2016 | 725 | 0.660 |
Why?
|
Colectomy | 2 | 2012 | 683 | 0.570 |
Why?
|
Markov Chains | 15 | 2016 | 969 | 0.550 |
Why?
|
Economic Competition | 2 | 2016 | 214 | 0.530 |
Why?
|
Cost Control | 4 | 2013 | 624 | 0.530 |
Why?
|
Mass Screening | 18 | 2006 | 5255 | 0.510 |
Why?
|
Defibrillators, Implantable | 6 | 2010 | 1440 | 0.510 |
Why?
|
Health Policy | 10 | 2016 | 2661 | 0.500 |
Why?
|
Information Storage and Retrieval | 3 | 2009 | 824 | 0.480 |
Why?
|
United States | 63 | 2018 | 69872 | 0.470 |
Why?
|
Drug Approval | 3 | 2009 | 742 | 0.460 |
Why?
|
Drug Industry | 3 | 2009 | 746 | 0.460 |
Why?
|
Hypercholesterolemia | 7 | 2000 | 1151 | 0.460 |
Why?
|
Vaginal Smears | 4 | 2001 | 511 | 0.460 |
Why?
|
Industry | 2 | 2006 | 365 | 0.450 |
Why?
|
Cholesterol | 8 | 2000 | 2917 | 0.450 |
Why?
|
Evidence-Based Medicine | 6 | 2005 | 3610 | 0.440 |
Why?
|
Sulfonylurea Compounds | 2 | 2011 | 204 | 0.430 |
Why?
|
Multimedia | 5 | 2005 | 77 | 0.430 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2016 | 9959 | 0.430 |
Why?
|
Utilization Review | 2 | 2005 | 392 | 0.420 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2011 | 340 | 0.410 |
Why?
|
Death, Sudden, Cardiac | 3 | 2018 | 1541 | 0.410 |
Why?
|
Gaucher Disease | 7 | 1998 | 112 | 0.400 |
Why?
|
Reimbursement, Incentive | 4 | 2013 | 540 | 0.390 |
Why?
|
Coronary Disease | 14 | 2000 | 6077 | 0.390 |
Why?
|
Mesalamine | 1 | 2011 | 136 | 0.380 |
Why?
|
Colonic Pouches | 1 | 2012 | 121 | 0.380 |
Why?
|
Kyphoplasty | 1 | 2011 | 44 | 0.380 |
Why?
|
Decision Making | 4 | 2011 | 3887 | 0.370 |
Why?
|
Health Care Reform | 5 | 2016 | 1261 | 0.370 |
Why?
|
Organizational Policy | 5 | 2008 | 429 | 0.370 |
Why?
|
Technology, High-Cost | 1 | 2010 | 32 | 0.370 |
Why?
|
Azathioprine | 1 | 2011 | 353 | 0.360 |
Why?
|
Androgen Antagonists | 3 | 2012 | 1377 | 0.360 |
Why?
|
Vertebroplasty | 1 | 2011 | 77 | 0.360 |
Why?
|
Low Back Pain | 1 | 2018 | 956 | 0.350 |
Why?
|
Private Sector | 3 | 2013 | 392 | 0.350 |
Why?
|
Colitis, Ulcerative | 2 | 2012 | 1912 | 0.350 |
Why?
|
Health Services | 3 | 2013 | 758 | 0.350 |
Why?
|
Academies and Institutes | 1 | 2011 | 317 | 0.340 |
Why?
|
Insurance Coverage | 4 | 2008 | 1901 | 0.340 |
Why?
|
Osteoporosis | 2 | 2011 | 1580 | 0.340 |
Why?
|
Watchful Waiting | 2 | 2012 | 492 | 0.340 |
Why?
|
Decision Support Techniques | 16 | 2014 | 1956 | 0.340 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2012 | 806 | 0.330 |
Why?
|
Glucosylceramidase | 4 | 1994 | 124 | 0.320 |
Why?
|
Device Approval | 1 | 2010 | 163 | 0.320 |
Why?
|
Myocardial Infarction | 10 | 2014 | 11727 | 0.320 |
Why?
|
Insurance Claim Reporting | 2 | 2008 | 163 | 0.320 |
Why?
|
Capsule Endoscopy | 1 | 2009 | 125 | 0.310 |
Why?
|
Hypoglycemic Agents | 7 | 2014 | 2872 | 0.310 |
Why?
|
Fast Foods | 1 | 2010 | 197 | 0.310 |
Why?
|
Taxes | 1 | 2010 | 221 | 0.310 |
Why?
|
Equipment and Supplies | 2 | 2010 | 281 | 0.310 |
Why?
|
Tomography | 1 | 2009 | 390 | 0.300 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 1999 | 339 | 0.300 |
Why?
|
Decision Making, Organizational | 2 | 2004 | 139 | 0.300 |
Why?
|
Preimplantation Diagnosis | 1 | 2009 | 151 | 0.290 |
Why?
|
Prostatectomy | 2 | 2012 | 1890 | 0.280 |
Why?
|
Humans | 136 | 2018 | 744343 | 0.280 |
Why?
|
Government Regulation | 2 | 2010 | 522 | 0.280 |
Why?
|
Sodium, Dietary | 1 | 2010 | 418 | 0.280 |
Why?
|
Pattern Recognition, Automated | 2 | 2009 | 1005 | 0.280 |
Why?
|
Cystic Fibrosis | 3 | 2009 | 1177 | 0.270 |
Why?
|
Nutrition Policy | 1 | 2010 | 488 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2016 | 5319 | 0.260 |
Why?
|
Alendronate | 1 | 2006 | 171 | 0.260 |
Why?
|
Efficiency | 2 | 2008 | 462 | 0.250 |
Why?
|
Pharmacogenetics | 1 | 2009 | 675 | 0.250 |
Why?
|
Models, Econometric | 4 | 2011 | 218 | 0.250 |
Why?
|
Terminally Ill | 1 | 2007 | 238 | 0.250 |
Why?
|
Insurance, Health | 4 | 2008 | 2494 | 0.250 |
Why?
|
Long-Term Care | 2 | 2004 | 607 | 0.250 |
Why?
|
Costs and Cost Analysis | 13 | 2010 | 1681 | 0.250 |
Why?
|
Spinal Fractures | 1 | 2011 | 696 | 0.240 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9274 | 0.240 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2001 | 2020 | 0.240 |
Why?
|
Teriparatide | 1 | 2006 | 225 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2014 | 11725 | 0.240 |
Why?
|
Insurance Claim Review | 2 | 2008 | 720 | 0.240 |
Why?
|
Terminal Care | 2 | 2007 | 1694 | 0.230 |
Why?
|
Intestine, Small | 1 | 2009 | 1241 | 0.220 |
Why?
|
Protein C | 1 | 2003 | 138 | 0.220 |
Why?
|
Disease | 1 | 2008 | 680 | 0.220 |
Why?
|
Monte Carlo Method | 5 | 2014 | 1254 | 0.220 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2004 | 161 | 0.220 |
Why?
|
Aged | 48 | 2018 | 163280 | 0.210 |
Why?
|
Activities of Daily Living | 4 | 2008 | 2418 | 0.210 |
Why?
|
Heart Arrest | 2 | 2003 | 1470 | 0.210 |
Why?
|
Drug Costs | 3 | 2013 | 1105 | 0.210 |
Why?
|
Infertility, Female | 1 | 2008 | 787 | 0.210 |
Why?
|
Sensitivity and Specificity | 20 | 2010 | 14722 | 0.210 |
Why?
|
Prostatic Neoplasms | 4 | 2012 | 11124 | 0.210 |
Why?
|
Orphan Drug Production | 2 | 1992 | 50 | 0.200 |
Why?
|
Heparin | 2 | 1999 | 1637 | 0.200 |
Why?
|
Tibial Fractures | 1 | 2004 | 269 | 0.200 |
Why?
|
Reimbursement Mechanisms | 1 | 2007 | 670 | 0.200 |
Why?
|
Blood Glucose | 4 | 2014 | 6256 | 0.200 |
Why?
|
Research Support as Topic | 3 | 2011 | 705 | 0.200 |
Why?
|
Patient-Centered Care | 1 | 2011 | 1439 | 0.200 |
Why?
|
Terminology as Topic | 1 | 2008 | 1547 | 0.200 |
Why?
|
Orchiectomy | 2 | 2000 | 474 | 0.200 |
Why?
|
Quality of Life | 11 | 2012 | 12804 | 0.190 |
Why?
|
Angioplasty | 2 | 2014 | 364 | 0.190 |
Why?
|
Practice Guidelines as Topic | 5 | 2005 | 7279 | 0.190 |
Why?
|
Drug Discovery | 1 | 2009 | 1058 | 0.190 |
Why?
|
Aircraft | 1 | 2001 | 123 | 0.190 |
Why?
|
Financing, Personal | 2 | 2013 | 308 | 0.190 |
Why?
|
Diethylstilbestrol | 1 | 2000 | 93 | 0.190 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 375 | 0.190 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 1071 | 0.190 |
Why?
|
Thiazolidinediones | 2 | 2014 | 476 | 0.180 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2002 | 214 | 0.180 |
Why?
|
California | 8 | 2008 | 1402 | 0.180 |
Why?
|
Endometriosis | 1 | 2008 | 839 | 0.180 |
Why?
|
Body Weight | 1 | 2011 | 4669 | 0.180 |
Why?
|
Laparoscopy | 2 | 2011 | 2151 | 0.180 |
Why?
|
Models, Economic | 3 | 2013 | 713 | 0.180 |
Why?
|
Venous Thrombosis | 2 | 1999 | 1239 | 0.180 |
Why?
|
Influenza Vaccines | 3 | 2014 | 738 | 0.180 |
Why?
|
Influenza, Human | 4 | 2014 | 1479 | 0.180 |
Why?
|
Intensive Care Units | 3 | 2008 | 3679 | 0.170 |
Why?
|
Managed Care Programs | 1 | 2004 | 950 | 0.170 |
Why?
|
Bone Density Conservation Agents | 1 | 2006 | 773 | 0.170 |
Why?
|
Cataract Extraction | 1 | 2003 | 481 | 0.160 |
Why?
|
Biological Products | 1 | 2007 | 860 | 0.160 |
Why?
|
Anticoagulants | 4 | 2016 | 4599 | 0.160 |
Why?
|
Ultraviolet Therapy | 1 | 1998 | 81 | 0.160 |
Why?
|
Mass Vaccination | 2 | 2009 | 105 | 0.160 |
Why?
|
Research | 3 | 2011 | 1999 | 0.160 |
Why?
|
Electric Countershock | 1 | 2001 | 534 | 0.160 |
Why?
|
Female | 61 | 2018 | 380194 | 0.160 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2795 | 0.160 |
Why?
|
Streptococcal Infections | 1 | 2002 | 638 | 0.160 |
Why?
|
Health Care Rationing | 1 | 2001 | 437 | 0.160 |
Why?
|
Caregivers | 2 | 2011 | 2094 | 0.150 |
Why?
|
Male | 57 | 2018 | 350118 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3158 | 0.150 |
Why?
|
Age Factors | 9 | 2018 | 18370 | 0.150 |
Why?
|
Osteogenesis | 1 | 2004 | 1299 | 0.150 |
Why?
|
Interviews as Topic | 5 | 2005 | 2539 | 0.150 |
Why?
|
Life Expectancy | 6 | 2013 | 1184 | 0.150 |
Why?
|
Receptor, erbB-2 | 1 | 2007 | 2416 | 0.150 |
Why?
|
Crohn Disease | 1 | 2009 | 2303 | 0.140 |
Why?
|
Attitude to Health | 3 | 2008 | 2052 | 0.140 |
Why?
|
Quality Assurance, Health Care | 4 | 2008 | 2212 | 0.140 |
Why?
|
State Medicine | 2 | 2008 | 217 | 0.140 |
Why?
|
Decision Trees | 6 | 2016 | 506 | 0.140 |
Why?
|
Government Agencies | 1 | 1996 | 156 | 0.140 |
Why?
|
Disease Outbreaks | 3 | 2010 | 1772 | 0.140 |
Why?
|
Survival Analysis | 7 | 2007 | 10252 | 0.140 |
Why?
|
Financing, Government | 2 | 2009 | 468 | 0.130 |
Why?
|
Artificial Intelligence | 1 | 2008 | 2214 | 0.130 |
Why?
|
Stroke | 5 | 2016 | 9981 | 0.130 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2000 | 1524 | 0.130 |
Why?
|
Geriatric Assessment | 5 | 2008 | 1372 | 0.130 |
Why?
|
Polymerase Chain Reaction | 2 | 2002 | 6171 | 0.130 |
Why?
|
Dermatologic Agents | 1 | 1998 | 278 | 0.130 |
Why?
|
Publishing | 1 | 2002 | 833 | 0.130 |
Why?
|
Medical Informatics | 1 | 2002 | 745 | 0.120 |
Why?
|
Recombinant Proteins | 2 | 2007 | 6622 | 0.120 |
Why?
|
Quality of Health Care | 3 | 2010 | 4371 | 0.120 |
Why?
|
Software | 5 | 2008 | 4443 | 0.120 |
Why?
|
Hyperlipidemias | 2 | 2002 | 789 | 0.120 |
Why?
|
Hospitals, Veterans | 1 | 1996 | 404 | 0.120 |
Why?
|
Visual Acuity | 1 | 2003 | 2530 | 0.120 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2759 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.120 |
Why?
|
Treatment Outcome | 18 | 2014 | 63114 | 0.120 |
Why?
|
Socioeconomic Factors | 4 | 2018 | 7785 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 2 | 2006 | 875 | 0.120 |
Why?
|
Hypolipidemic Agents | 1 | 1998 | 604 | 0.120 |
Why?
|
Health Services for the Aged | 2 | 2004 | 269 | 0.110 |
Why?
|
Coronary Angiography | 2 | 2010 | 4577 | 0.110 |
Why?
|
Brachytherapy | 2 | 2012 | 1248 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2008 | 1786 | 0.110 |
Why?
|
Middle Aged | 33 | 2013 | 213383 | 0.110 |
Why?
|
Hospital Costs | 3 | 2007 | 985 | 0.110 |
Why?
|
Survivors | 1 | 2003 | 2291 | 0.110 |
Why?
|
Estrogen Replacement Therapy | 2 | 2002 | 1203 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2000 | 979 | 0.110 |
Why?
|
Attitude to Computers | 2 | 2005 | 202 | 0.110 |
Why?
|
Risk Factors | 20 | 2018 | 72290 | 0.110 |
Why?
|
Atrial Appendage | 1 | 2016 | 283 | 0.110 |
Why?
|
Cost of Illness | 4 | 2012 | 1859 | 0.100 |
Why?
|
Human Growth Hormone | 2 | 2008 | 683 | 0.100 |
Why?
|
Public Policy | 1 | 1996 | 572 | 0.100 |
Why?
|
Methotrexate | 1 | 1998 | 1727 | 0.100 |
Why?
|
Prenatal Diagnosis | 2 | 1991 | 1236 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 3255 | 0.100 |
Why?
|
Rhabdomyolysis | 1 | 2013 | 150 | 0.100 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2011 | 71 | 0.100 |
Why?
|
Health Status Indicators | 3 | 2008 | 969 | 0.100 |
Why?
|
Patient Satisfaction | 3 | 2011 | 3396 | 0.100 |
Why?
|
Choice Behavior | 1 | 1997 | 803 | 0.100 |
Why?
|
United States Food and Drug Administration | 2 | 2010 | 1584 | 0.100 |
Why?
|
Geography | 1 | 2013 | 669 | 0.100 |
Why?
|
Hospitals | 1 | 2005 | 3952 | 0.100 |
Why?
|
Coronary Artery Bypass | 3 | 2014 | 2289 | 0.100 |
Why?
|
Genetic Testing | 3 | 2006 | 3444 | 0.100 |
Why?
|
Pravastatin | 1 | 2013 | 395 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2018 | 57776 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8642 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2002 | 2026 | 0.090 |
Why?
|
Health Services Accessibility | 2 | 2005 | 5137 | 0.090 |
Why?
|
Psoriasis | 1 | 1998 | 898 | 0.090 |
Why?
|
beta-Alanine | 1 | 2010 | 74 | 0.090 |
Why?
|
Sex Factors | 5 | 2018 | 10397 | 0.090 |
Why?
|
Adult | 29 | 2010 | 214055 | 0.090 |
Why?
|
Life Support Care | 1 | 2011 | 228 | 0.090 |
Why?
|
Jurisprudence | 1 | 2010 | 110 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 1997 | 1504 | 0.090 |
Why?
|
Nephrons | 1 | 2011 | 220 | 0.090 |
Why?
|
Expressed Emotion | 1 | 2010 | 92 | 0.090 |
Why?
|
Carotid Stenosis | 1 | 1997 | 854 | 0.090 |
Why?
|
Equipment Failure | 2 | 2010 | 578 | 0.090 |
Why?
|
Eligibility Determination | 1 | 2013 | 403 | 0.090 |
Why?
|
Risk | 3 | 2018 | 9687 | 0.090 |
Why?
|
Sepsis | 1 | 2003 | 2593 | 0.090 |
Why?
|
Subject Headings | 1 | 2008 | 17 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 1998 | 2046 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2007 | 20822 | 0.080 |
Why?
|
Therapeutic Equivalency | 1 | 2009 | 141 | 0.080 |
Why?
|
Electrocardiography | 3 | 1999 | 6442 | 0.080 |
Why?
|
Diabetes Complications | 2 | 2014 | 1359 | 0.080 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2009 | 113 | 0.080 |
Why?
|
Public Health | 1 | 2002 | 2603 | 0.080 |
Why?
|
Object Attachment | 1 | 2011 | 313 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2050 | 0.080 |
Why?
|
Probability | 3 | 2003 | 2505 | 0.080 |
Why?
|
Drugs, Generic | 2 | 2014 | 421 | 0.080 |
Why?
|
Psychometrics | 1 | 1998 | 3002 | 0.080 |
Why?
|
Pregnancy, Multiple | 1 | 2009 | 217 | 0.080 |
Why?
|
Physicians | 2 | 2004 | 4567 | 0.080 |
Why?
|
Diet, Sodium-Restricted | 1 | 2010 | 287 | 0.080 |
Why?
|
Drug Resistance, Microbial | 2 | 1989 | 862 | 0.080 |
Why?
|
Observation | 1 | 2010 | 312 | 0.080 |
Why?
|
Standard of Care | 1 | 2011 | 564 | 0.080 |
Why?
|
Twins | 1 | 2009 | 339 | 0.080 |
Why?
|
Multivariate Analysis | 5 | 2005 | 12245 | 0.080 |
Why?
|
Gastrointestinal Agents | 1 | 2012 | 494 | 0.080 |
Why?
|
Athletic Performance | 1 | 2008 | 95 | 0.070 |
Why?
|
Exercise Test | 2 | 1999 | 2074 | 0.070 |
Why?
|
Hypoglycemia | 2 | 2010 | 861 | 0.070 |
Why?
|
Coronary Artery Disease | 3 | 2014 | 6487 | 0.070 |
Why?
|
Logistic Models | 4 | 2010 | 13408 | 0.070 |
Why?
|
Decision Making, Computer-Assisted | 2 | 1998 | 150 | 0.070 |
Why?
|
Forecasting | 3 | 2011 | 2951 | 0.070 |
Why?
|
Warfarin | 2 | 2016 | 1496 | 0.070 |
Why?
|
Echocardiography | 1 | 1999 | 5102 | 0.070 |
Why?
|
Smoking Cessation | 1 | 1998 | 2071 | 0.070 |
Why?
|
Kidney Failure, Chronic | 3 | 2013 | 2538 | 0.070 |
Why?
|
Pregnancy Rate | 1 | 2009 | 643 | 0.070 |
Why?
|
Health Services Needs and Demand | 2 | 2004 | 1411 | 0.070 |
Why?
|
Computer Literacy | 2 | 2005 | 43 | 0.070 |
Why?
|
Blastocyst | 1 | 2009 | 424 | 0.070 |
Why?
|
Public Sector | 1 | 2007 | 265 | 0.070 |
Why?
|
Canada | 2 | 2008 | 2065 | 0.070 |
Why?
|
Evaluation Studies as Topic | 2 | 2007 | 1681 | 0.070 |
Why?
|
Clinical Trials as Topic | 5 | 2014 | 7913 | 0.070 |
Why?
|
Hospitalization | 4 | 2013 | 10262 | 0.070 |
Why?
|
Exercise | 4 | 2008 | 5615 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.070 |
Why?
|
Anthrax Vaccines | 1 | 2005 | 14 | 0.070 |
Why?
|
Heart Diseases | 3 | 2002 | 2788 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2010 | 850 | 0.060 |
Why?
|
Incidental Findings | 1 | 2010 | 689 | 0.060 |
Why?
|
Disease Progression | 4 | 2013 | 13284 | 0.060 |
Why?
|
Nephrectomy | 1 | 2011 | 1050 | 0.060 |
Why?
|
Atrial Fibrillation | 2 | 2016 | 5034 | 0.060 |
Why?
|
Algorithms | 4 | 2009 | 13881 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 2010 | 935 | 0.060 |
Why?
|
Geriatric Nursing | 1 | 2005 | 39 | 0.060 |
Why?
|
Clinical Protocols | 1 | 1991 | 1462 | 0.060 |
Why?
|
Anthrax | 1 | 2005 | 88 | 0.060 |
Why?
|
Computer Simulation | 2 | 2010 | 6196 | 0.060 |
Why?
|
Regression Analysis | 2 | 2010 | 6459 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2010 | 996 | 0.060 |
Why?
|
Recurrence | 4 | 2000 | 8340 | 0.060 |
Why?
|
Bioterrorism | 1 | 2005 | 143 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2011 | 12026 | 0.060 |
Why?
|
Adjuvants, Immunologic | 1 | 2009 | 1000 | 0.060 |
Why?
|
Direct Service Costs | 2 | 2014 | 62 | 0.060 |
Why?
|
Rate Setting and Review | 1 | 2004 | 41 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2009 | 602 | 0.060 |
Why?
|
Health Facility Merger | 1 | 2004 | 53 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3507 | 0.060 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2008 | 430 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 1997 | 3057 | 0.060 |
Why?
|
Economics | 1 | 2004 | 146 | 0.060 |
Why?
|
Abortion, Spontaneous | 1 | 2009 | 544 | 0.060 |
Why?
|
Physician Executives | 1 | 2004 | 128 | 0.060 |
Why?
|
Commerce | 1 | 2009 | 592 | 0.060 |
Why?
|
Capitation Fee | 1 | 2004 | 116 | 0.060 |
Why?
|
Time Factors | 6 | 2013 | 40075 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2000 | 1205 | 0.060 |
Why?
|
Japan | 1 | 2008 | 1360 | 0.060 |
Why?
|
Models, Theoretical | 3 | 2014 | 3589 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4933 | 0.060 |
Why?
|
Patient Care | 1 | 2009 | 640 | 0.060 |
Why?
|
Boronic Acids | 1 | 2007 | 965 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15165 | 0.060 |
Why?
|
APACHE | 1 | 2003 | 277 | 0.060 |
Why?
|
Hypertension | 4 | 2013 | 8480 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2006 | 618 | 0.050 |
Why?
|
Cohort Studies | 5 | 2007 | 40561 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1536 | 0.050 |
Why?
|
Pregnancy | 4 | 2009 | 29144 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2804 | 0.050 |
Why?
|
New York City | 1 | 2004 | 710 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2006 | 781 | 0.050 |
Why?
|
Myocardial Revascularization | 2 | 2003 | 841 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2010 | 20129 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 3 | 1996 | 780 | 0.050 |
Why?
|
Affect | 1 | 2010 | 1476 | 0.050 |
Why?
|
Fee-for-Service Plans | 2 | 2004 | 694 | 0.050 |
Why?
|
Social Responsibility | 1 | 2005 | 389 | 0.050 |
Why?
|
Developed Countries | 1 | 2004 | 437 | 0.050 |
Why?
|
Mortality | 3 | 1999 | 2864 | 0.050 |
Why?
|
Pyrazines | 1 | 2007 | 1230 | 0.050 |
Why?
|
Patient Selection | 2 | 2013 | 4215 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2011 | 1209 | 0.050 |
Why?
|
Reproducibility of Results | 7 | 2005 | 19905 | 0.050 |
Why?
|
Fertilization in Vitro | 1 | 2009 | 1284 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3068 | 0.050 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6489 | 0.050 |
Why?
|
Bacterial Infections | 1 | 1989 | 1401 | 0.050 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 1965 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2158 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2014 | 2337 | 0.050 |
Why?
|
Bacteria | 2 | 1989 | 2114 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 1989 | 7181 | 0.050 |
Why?
|
Survival Rate | 4 | 2016 | 12788 | 0.050 |
Why?
|
Cross Infection | 1 | 1989 | 1416 | 0.050 |
Why?
|
Radiography | 2 | 2009 | 7023 | 0.040 |
Why?
|
Data Collection | 2 | 2002 | 3341 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 639 | 0.040 |
Why?
|
Sex Distribution | 1 | 2005 | 2297 | 0.040 |
Why?
|
Ventricular Fibrillation | 1 | 2002 | 538 | 0.040 |
Why?
|
Analysis of Variance | 2 | 1999 | 6365 | 0.040 |
Why?
|
Thallium Radioisotopes | 1 | 1999 | 139 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1994 | 3336 | 0.040 |
Why?
|
Medicare Part C | 1 | 2004 | 296 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 1984 | 1179 | 0.040 |
Why?
|
Dipyridamole | 1 | 1999 | 145 | 0.040 |
Why?
|
Labor, Obstetric | 1 | 2002 | 333 | 0.040 |
Why?
|
Dobutamine | 1 | 1999 | 123 | 0.040 |
Why?
|
Acute Disease | 2 | 2008 | 7149 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 35421 | 0.040 |
Why?
|
Self Concept | 1 | 2005 | 1025 | 0.040 |
Why?
|
Hemorrhage | 3 | 2014 | 3461 | 0.040 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1999 | 177 | 0.040 |
Why?
|
Histamine H2 Antagonists | 1 | 2000 | 165 | 0.040 |
Why?
|
Schizophrenia | 1 | 1997 | 6882 | 0.040 |
Why?
|
Needs Assessment | 1 | 2004 | 1147 | 0.040 |
Why?
|
Nursing Homes | 1 | 2006 | 1036 | 0.040 |
Why?
|
Benchmarking | 1 | 2005 | 1042 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3479 | 0.040 |
Why?
|
Synostosis | 1 | 1998 | 43 | 0.040 |
Why?
|
Comorbidity | 2 | 2013 | 10388 | 0.040 |
Why?
|
Cities | 2 | 2014 | 513 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 8949 | 0.040 |
Why?
|
Postoperative Period | 1 | 2003 | 1842 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2002 | 15076 | 0.040 |
Why?
|
Akathisia, Drug-Induced | 1 | 1997 | 67 | 0.040 |
Why?
|
Primary Prevention | 2 | 2013 | 1167 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2758 | 0.040 |
Why?
|
Incidence | 3 | 2013 | 20947 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2004 | 2453 | 0.040 |
Why?
|
Parkinson Disease, Secondary | 1 | 1997 | 126 | 0.040 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1997 | 163 | 0.040 |
Why?
|
Models, Statistical | 2 | 2005 | 5102 | 0.040 |
Why?
|
Cost Allocation | 1 | 1996 | 51 | 0.040 |
Why?
|
Tachycardia, Ventricular | 2 | 2002 | 1273 | 0.040 |
Why?
|
Diabetic Angiopathies | 1 | 2002 | 818 | 0.040 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1998 | 437 | 0.040 |
Why?
|
Child | 6 | 2011 | 77709 | 0.040 |
Why?
|
Universities | 1 | 2002 | 956 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2007 | 6895 | 0.030 |
Why?
|
Risk Assessment | 3 | 2007 | 23338 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 1997 | 205 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2007 | 2149 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2005 | 2268 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1999 | 535 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1873 | 0.030 |
Why?
|
Meta-Analysis as Topic | 3 | 1996 | 1344 | 0.030 |
Why?
|
Pain | 1 | 2011 | 4986 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2008 | 1972 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3143 | 0.030 |
Why?
|
Travel | 1 | 2001 | 788 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2001 | 783 | 0.030 |
Why?
|
Septal Occluder Device | 1 | 2016 | 128 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2002 | 906 | 0.030 |
Why?
|
Prognosis | 3 | 2007 | 29063 | 0.030 |
Why?
|
Mammography | 1 | 2006 | 2476 | 0.030 |
Why?
|
Quality Control | 1 | 1998 | 841 | 0.030 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2000 | 373 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 2031 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2000 | 526 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 1997 | 2886 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1999 | 977 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15540 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.030 |
Why?
|
Blood Pressure | 1 | 2010 | 8554 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4262 | 0.030 |
Why?
|
Hygiene | 1 | 2014 | 98 | 0.030 |
Why?
|
History, 20th Century | 1 | 2002 | 2740 | 0.030 |
Why?
|
Pandemics | 1 | 2014 | 8388 | 0.030 |
Why?
|
Audiovisual Aids | 1 | 1994 | 92 | 0.030 |
Why?
|
Preoperative Care | 1 | 2003 | 2250 | 0.030 |
Why?
|
Patient Isolation | 1 | 2014 | 100 | 0.030 |
Why?
|
National Health Programs | 1 | 1997 | 445 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2007 | 11524 | 0.030 |
Why?
|
Income | 2 | 1999 | 1913 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3309 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 7729 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5720 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2007 | 5317 | 0.030 |
Why?
|
Health Status | 2 | 2004 | 4034 | 0.030 |
Why?
|
Vaccination | 1 | 2005 | 3278 | 0.030 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 257 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2000 | 782 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1998 | 2421 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1996 | 1144 | 0.030 |
Why?
|
Preventive Medicine | 1 | 1994 | 264 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4982 | 0.030 |
Why?
|
Inpatients | 1 | 2004 | 2518 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2007 | 11031 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2003 | 12354 | 0.030 |
Why?
|
Insurance Benefits | 1 | 1994 | 183 | 0.030 |
Why?
|
Insulin | 1 | 2007 | 6580 | 0.030 |
Why?
|
Endarterectomy, Carotid | 1 | 1997 | 546 | 0.030 |
Why?
|
Stents | 1 | 2003 | 3280 | 0.020 |
Why?
|
Models, Biological | 1 | 1987 | 9583 | 0.020 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 1991 | 92 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1996 | 1240 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2000 | 2494 | 0.020 |
Why?
|
Odds Ratio | 1 | 2003 | 9849 | 0.020 |
Why?
|
Coronary Thrombosis | 1 | 2014 | 495 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 1995 | 1092 | 0.020 |
Why?
|
Health Education | 1 | 1997 | 1056 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1991 | 768 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1997 | 1678 | 0.020 |
Why?
|
Adolescent | 6 | 2010 | 85781 | 0.020 |
Why?
|
Iopamidol | 1 | 2010 | 191 | 0.020 |
Why?
|
Patient Admission | 1 | 1997 | 1380 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2013 | 77449 | 0.020 |
Why?
|
Diagnosis-Related Groups | 2 | 1997 | 455 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 588 | 0.020 |
Why?
|
Adenosine | 1 | 2014 | 825 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2000 | 3798 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 547 | 0.020 |
Why?
|
Ticlopidine | 1 | 2014 | 899 | 0.020 |
Why?
|
Body Composition | 2 | 2008 | 2401 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8664 | 0.020 |
Why?
|
Gram-Negative Bacteria | 1 | 1989 | 270 | 0.020 |
Why?
|
Total Quality Management | 1 | 2009 | 274 | 0.020 |
Why?
|
Life Style | 3 | 2007 | 3835 | 0.020 |
Why?
|
Abortion, Eugenic | 1 | 1987 | 41 | 0.020 |
Why?
|
Immunization Programs | 1 | 2009 | 260 | 0.020 |
Why?
|
Bacterial Physiological Phenomena | 1 | 1987 | 122 | 0.020 |
Why?
|
Basal Metabolism | 1 | 2008 | 168 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2007 | 57 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2002 | 2356 | 0.020 |
Why?
|
Attitude | 1 | 2011 | 776 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 1999 | 2376 | 0.020 |
Why?
|
Cryosurgery | 1 | 2011 | 453 | 0.020 |
Why?
|
Research Design | 2 | 1999 | 5987 | 0.020 |
Why?
|
Cardiology | 1 | 1997 | 1668 | 0.020 |
Why?
|
Prevalence | 3 | 2010 | 15226 | 0.020 |
Why?
|
Pilot Projects | 1 | 1998 | 8324 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2009 | 397 | 0.020 |
Why?
|
Societies, Medical | 1 | 1997 | 3743 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 855 | 0.020 |
Why?
|
Community Health Services | 1 | 2010 | 650 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 2004 | 378 | 0.010 |
Why?
|
Seasons | 1 | 2009 | 1493 | 0.010 |
Why?
|
Insurance Selection Bias | 1 | 2004 | 67 | 0.010 |
Why?
|
Muscle Strength | 1 | 2008 | 592 | 0.010 |
Why?
|
Attitude of Health Personnel | 2 | 1990 | 3843 | 0.010 |
Why?
|
Genotype | 2 | 2014 | 12951 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.010 |
Why?
|
Prospective Payment System | 1 | 1984 | 133 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4328 | 0.010 |
Why?
|
Demography | 1 | 1988 | 1656 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6933 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2000 | 9239 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2002 | 25625 | 0.010 |
Why?
|
Health Maintenance Organizations | 1 | 2005 | 642 | 0.010 |
Why?
|
Attitude to Death | 1 | 2005 | 382 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
Mutation | 1 | 2006 | 29786 | 0.010 |
Why?
|
Longevity | 1 | 1989 | 1070 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2618 | 0.010 |
Why?
|
Coronary Restenosis | 1 | 2003 | 424 | 0.010 |
Why?
|
Educational Status | 1 | 2008 | 2540 | 0.010 |
Why?
|
Databases as Topic | 1 | 2002 | 475 | 0.010 |
Why?
|
Weight Gain | 1 | 2010 | 2292 | 0.010 |
Why?
|
Risk Adjustment | 1 | 2004 | 594 | 0.010 |
Why?
|
Heartburn | 1 | 2000 | 68 | 0.010 |
Why?
|
Antacids | 1 | 2000 | 99 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 3913 | 0.010 |
Why?
|
Goserelin | 1 | 1999 | 129 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2000 | 17446 | 0.010 |
Why?
|
Esophagoscopy | 1 | 2000 | 390 | 0.010 |
Why?
|
Manitoba | 1 | 1997 | 23 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2005 | 1431 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 614 | 0.010 |
Why?
|
Leuprolide | 1 | 1999 | 321 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2009 | 2987 | 0.010 |
Why?
|
Prospective Studies | 2 | 2006 | 53288 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5300 | 0.010 |
Why?
|
Value of Life | 1 | 1997 | 97 | 0.010 |
Why?
|
Michigan | 1 | 1997 | 350 | 0.010 |
Why?
|
Joints | 1 | 1998 | 326 | 0.010 |
Why?
|
Leisure Activities | 1 | 1997 | 311 | 0.010 |
Why?
|
Faculty, Medical | 1 | 1984 | 1181 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3305 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1998 | 880 | 0.010 |
Why?
|
Heart Failure | 2 | 2013 | 10900 | 0.010 |
Why?
|
Medicaid | 1 | 1988 | 2736 | 0.010 |
Why?
|
Remission Induction | 1 | 2000 | 2386 | 0.010 |
Why?
|
Bone Density | 1 | 2007 | 3468 | 0.010 |
Why?
|
Computer Graphics | 1 | 1994 | 361 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3064 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9146 | 0.010 |
Why?
|
Genetic Markers | 1 | 1998 | 2634 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39050 | 0.010 |
Why?
|
Risk-Taking | 1 | 1997 | 986 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1997 | 2971 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1998 | 1416 | 0.010 |
Why?
|
Employment | 1 | 1997 | 1132 | 0.010 |
Why?
|
Pedigree | 1 | 1998 | 4644 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2000 | 1637 | 0.010 |
Why?
|
Infant | 1 | 1992 | 35136 | 0.010 |
Why?
|
HIV Infections | 1 | 1996 | 16718 | 0.010 |
Why?
|
Patient Readmission | 1 | 2002 | 3114 | 0.000 |
Why?
|
Primary Health Care | 1 | 2005 | 4558 | 0.000 |
Why?
|
ROC Curve | 1 | 1996 | 3527 | 0.000 |
Why?
|
Thrombosis | 1 | 2002 | 2968 | 0.000 |
Why?
|
Bone and Bones | 1 | 1998 | 2575 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1997 | 5078 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1989 | 620 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2002 | 13989 | 0.000 |
Why?
|
Blood Pressure Determination | 1 | 1990 | 634 | 0.000 |
Why?
|
Smoking | 1 | 2002 | 8987 | 0.000 |
Why?
|
Diet | 1 | 2002 | 7939 | 0.000 |
Why?
|
Length of Stay | 1 | 1997 | 6309 | 0.000 |
Why?
|
Young Adult | 1 | 2010 | 56430 | 0.000 |
Why?
|
Neoplasms | 1 | 1991 | 21683 | 0.000 |
Why?
|
Obesity | 1 | 2002 | 12745 | 0.000 |
Why?
|
Child, Preschool | 1 | 1995 | 41006 | 0.000 |
Why?
|